LexDanaLexDanabeta
Inventor

Burcu CALISKAN

Inventor
TR

Overview

2→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
11,986,475Compositions and methods for treating cancer202411,622,966Highly potent TACC3 inhibitor as a novel anticancer drug candidate2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to A2A PHARMACEUTICALS INC (2)· patent assignee history
2023–2024Patents assigned to ONCOCUBE THERAPEUTICS LLC (2)· patent assignee history
2023–2024Based in TR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
A2A PHARMACEUTICALS INC22023–2024
ONCOCUBE THERAPEUTICS LLC22023–2024
Locations
LocationPatentsSpan
TR22023–2024